Photo Neuro-Modulation Therapy to Adults

Overview

It is well-documented that mild cognitive impairment (MCI) is associated frontal lobe dysfunction and executive dysfunction. In addition, many studies reported high level of MCI symptoms among the elderly and the trend is increasing in Hong Kong. Based upon the link between MCI and frontal and executive function problems, it is conceivable that elderly who exhibits high levels of memory problems would exhibit frontal and executive function problems. To our knowledge, there is still a lack of effective treatment or therapy for MCI, it is important to investigate effective intervention that can efficiently improve the cognitive ability of MCI patients or patients with mild memory problems. The objective of the present study is to compare individuals with mild memory problems after the Photo neuro-modulation Therapy (PNMT) and those who do not. 40 middle aged and older adults were recruited from the subject database of the Neuropsychology Laboratory of The Chinese University of Hong Kong. Participants were divided randomly and equally into treatment group, as well as the placebo group. Several computerized executive function tests will be used before and after the treatment under the recording of near-infrared spectroscopy (NIRS), which estimates level of frontal activation. It is hypothesized that compared to participants without PNMT, those with PNMT will have a better performance in the executive function tasks and exhibit a higher frontal activation. The cognitive and neurophysiological results would provide evidences on the possibility of PNMT in treating individuals with mild memory problems, as well as with other mental disorders.

Full Title of Study: “Photo Neuro-Modulation Therapy to Middle Aged and Older Adults With Mild Memory Problem”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: June 2020

Interventions

  • Device: Photoneuromodulation therapy
    • low-level LED near-infrared (670-810nm) including MedX Health Model 1100 or WiseFori5-3800
  • Other: Sham
    • Sham, no active stimulation will be given to subjects

Arms, Groups and Cohorts

  • Experimental: Photoneuromodulation Therapy
    • In this study low-level LED near-infrared (670-810nm) including MedX Health Model 1100 or WiseFori5-3800 will be used. The United States Food and Drug Administration (FDA) has approved this type of device as imposing insignificant risk (FDA-cleared for home treatment, 2005). At each visit, LED clusters will be applied simultaneously for 20 minutes on the Fp1, Fp2 and Pz regions according to the International 10-20 system (Homan, Herman and Purdy, 1987) (energy density, 13 Joules/cm2 [J/cm2] per each LED cluster head placement). The total LED treatment time per visit was 20 minutes.
  • Sham Comparator: Control Group
    • Subject will not be given any active stimulation

Clinical Trial Outcome Measures

Primary Measures

  • N-Back Test (cognitive test battery)
    • Time Frame: through study completion, an average of 2 year
    • a digit n-back paradigm to assess working memory
  • Category Fluency Test
    • Time Frame: through study completion, an average of 2 year
    • a test to assess the ability to generate words that belong to a semantic category in a controlled manner
  • The Hong Kong List Learning Test
    • Time Frame: through study completion, an average of 2 year
    • a tests to assess memory function of the participants
  • The Chinese Version of the Mattis Dementia Rating Scale
    • Time Frame: through study completion, an average of 2 year
    • a test to estimate the global functioning level of the participants, lowest score is 0, highest score is 144, higher score means better global functioning level
  • NIRS Recording
    • Time Frame: through study completion, an average of 2 year
    • NIRS to record the hemodynamic response, measured in mmol/mm
  • EEG Recordings
    • Time Frame: through study completion, an average of 2 year
    • EEG is used to record electrical activity of the brain, measured in microvolts, EEG power spectrum
  • EEG Recordings
    • Time Frame: through study completion, an average of 2 year
    • EEG source localisation, measured in current density

Participating in This Clinical Trial

Inclusion Criteria

  • 40 middle age and older adults with aged 40 or above who have subjective memory complaints

Exclusion Criteria

  • A history of head injury, or any neurological/psychiatric disorders, and dementia will be excluded. In addition, a score higher than 7 on the short form of the Chinese Geriatric Depression Scale (CGDS-SF; Lee, Chiu, Kwok, & Leung, 1993)

Gender Eligibility: All

Minimum Age: 40 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Chinese University of Hong Kong
  • Provider of Information About this Clinical Study
    • Principal Investigator: Professor Chan Sui-yin Agnes, Professor Chan Sui-yin Agnes – Chinese University of Hong Kong

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.